Literature DB >> 17282687

Inhibition of Mitochondrial Permeability Transition Pore: A Possible Mechanism for Cardioprotection Conferred by Pretreatment with Tanshinone IIA.

Shi-Zhong Zhang1, Zhi-Guo Ye, Qiang Xia, Wei Zhang, Iain Bruce.   

Abstract

The objective of this study was to determine whether the mitochondrial permeability transition pore plays a role in cardioprotection induced by tanshinone IIA. Isolated rat hearts were subjected to 30 min regional ischemia by ligation of the left anterior descending artery followed by 120 min reperfusion. Ischemic preconditioning (IPC) was achieved by two 5-min periods of global ischemia separated by 5 min of reperfusion. Pretreatment with tanshinone reduced the infarct size which was associated with improved recovery of left ventricular contractility as with IPC. Perfusion with 100 muM 5-hydroxydecanoate (5-HD) attenuated the cardioprotection induced by tanshinone. In mitochondria isolated from untreated hearts, tanshinone inhibited pore opening dose-dependently, and this effect was abolished by blocking the mitochondrial ATP sensitive potassium channel with 5-HD. We conclude that pretreatment with tanshinone IIA provides similar cardioprotection to IPC, this effect may be via inhibiting the pore opening during reperfusion, and the mitochondrial ATP sensitive potassium channel may play a role in mediating the pore inhibition induced by tanshinone IIA.

Entities:  

Year:  2005        PMID: 17282687     DOI: 10.1109/IEMBS.2005.1616918

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  5 in total

1.  Study on optimisation of extraction process of tanshinone IIA and its mechanism of induction of gastric cancer SGC7901 cell apoptosis.

Authors:  Jianhong Hou; Jiantai He; Xin Jin; Tian Hu; Yangde Zhang
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-10-03

2.  Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway.

Authors:  Xun Yuan; Songbo Jing; Lingzhen Wu; Lianglong Chen; Jun Fang
Journal:  Exp Ther Med       Date:  2014-07-02       Impact factor: 2.447

3.  Tanshinone IIA Pretreatment Protects H9c2 Cells against Anoxia/Reoxygenation Injury: Involvement of the Translocation of Bcl-2 to Mitochondria Mediated by 14-3-3η.

Authors:  Zeyu Zhang; Huan He; Yang Qiao; Jiyi Huang; Zelong Wu; Ping Xu; Dong Yin; Ming He
Journal:  Oxid Med Cell Longev       Date:  2018-06-28       Impact factor: 6.543

Review 4.  Regulation of Mitochondrial Quality Control by Natural Drugs in the Treatment of Cardiovascular Diseases: Potential and Advantages.

Authors:  Xing Chang; Wenjin Zhang; Zhenyu Zhao; Chunxia Ma; Tian Zhang; Qingyan Meng; Peizheng Yan; Lei Zhang; Yuping Zhao
Journal:  Front Cell Dev Biol       Date:  2020-12-23

5.  Tanshinone IIA combined with CsA inhibit myocardial cell apoptosis induced by renal ischemia-reperfusion injury in obese rats.

Authors:  He Tai; Xiao-Lin Jiang; Zhi-Ming Lan; Yue Li; Liang Kong; Si-Cheng Yao; Nan Song; Mei-Jun Lv; Jin Wu; Ping Yang; Xuan-Si Xiao; Guan-Lin Yang; Jin-Song Kuang; Lian-Qun Jia
Journal:  BMC Complement Med Ther       Date:  2021-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.